AstraZeneca’s trial flop raises bigger questions around its pipeline
AstraZeneca‘s failed late-stage trial for Wainua was never expected to have a major financial impact on the company.…
AstraZeneca stock dives 9% after heart drug trial misses target
Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug…